• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VARIOUS ICDS; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VARIOUS ICDS; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) Back to Search Results
Device Problem Inappropriate/Inadequate Shock/Stimulation (1574)
Patient Problem Electric Shock (2554)
Event Date 01/01/2011
Event Type  malfunction  
Event Description
Cicenia, marianna, et al.(2023)."icd outcome in pediatric arrhythmogenic cardiomyopathy." international journal of cardiology, https://doi.Org/10.1016/j.Ijcard.2023.131381 it was reported in the above journal article that in nineteen pediatric patients with arrhythmogenic cardiomyopathy (acm) that underwent implantation of an implantable cardioverter defibrillator (icd) between january 2011 and december 2022 (15 patients were implanted with a subcutaneous icd, or s-icd, and 4 patients were implanted with a transvenous icd, or tv-icd), appropriate therapies occurred in a minority of primary prevention patients and frequently in secondary prevention patients.The rate of inappropriate shock therapy and device-related complications were rare and most often wound related.For tv-icd systems specifically: one patient required lead repositioning due to lead dislodgement.In another patient, an inappropriate shock occurred during stress exceeding the ventricular tachycardia (vt) detection rate threshold.In this last case, the ventricular fibrillation (vf)/vt-detection rate threshold was increased, and beta-blocker therapy optimized.Please see the attached article for further details.
 
Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VARIOUS ICDS
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18471378
MDR Text Key332985694
Report Number2124215-2024-00702
Device Sequence Number1
Product Code DXY
Combination Product (y/n)N
Reporter Country CodeIT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 01/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-